Arcturus Therapeutics Announces Strategic Collaboration with Thermo Fisher Scientific to Advance ARCT-032 for Cystic Fibrosis

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/22/2026

1. SPY
2. WBD
3. PSKY
4. NVDA
5. TSLA
6. USO
7. AMD
8. COHR
9. AMC
10. META

Go back to Arcturus Therapeutics Announces Strategic Collaboration with Thermo Fisher Scientific to Advance ARCT-032 for Cystic Fibrosis
AMERICAN RCT REIT (NASDAQ: ARCT) Delayed: 14.69 -1.34 (8.36%)
Previous Close $16.03    52 Week High $13.09 
Open $16.37    52 Week Low $5.54 
Day High $16.55    P/E N/A 
Day Low $14.60    EPS $-0.38 
Volume 1,002,997